Systemic chemotherapy in inoperable or metastatic bladder cancer

Aristotle Bamias; I. Tiliakos; Maria Karali; Meletios A Dimopoulos

doi:10.1093/annonc/mdj079

Related publications

Article2007

5040 POSTER Recurrent or metastatic endometrial cancer: Prognostic factors after taxane-based systemic chemotherapy

Giannis Mountzios, A. Bamias, D. Papadimitriou, E. Pissakas, George Bozas, G. Lainakis, Evangelos Lianos, Efstathios Kastritis, Meletios A Dimopoulos

Article2022

Activity of Cabazitaxel in Metastatic or Inoperable Locally Advanced Dedifferentiated Liposarcoma

Roberta Sanfilippo, Richard L. Hayward, Jammbe Musoro, Charlotte Benson, Michael Leahy, Antonella Brunello, Jean Yves Blay, Neeltje Steeghs, Ingrid M.E. Desar, Nasim Ali, Alice Hervieu, Khin Thway, Sandrine Marréaud, Saskia Litière, Bernd Kasper

Article2005

Neoadjuvant chemotherapy in invasive bladder cancer

Aristotle Bamias, Meletios A Dimopoulos

Article2006

Cisplatin versus carboplatin-based chemotherapy in inoperable or recurrent urothelial carcinoma: A retrospective analysis

Aristotelis Bamias, Efstathios Kastritis, George Bozas, Vassiliki Koutsoukou, N. Antoniou, H. Katsifotis, K. Konstantinidis, Andreas Skolarikos, C. Deliveliotis, Meletios A Dimopoulos

Article1999

Cisplatin versus carboplatin based chemotherapy as induction chemotherapy of bladder cancer

Gerasimos Aravantinos, Meletios A Dimopoulos, H. Athanasiou, George Fountzilas, E. Samantas, Christos Kiamouris, D. Skarlos